Daniel A. Rossignol

5.3k total citations · 3 hit papers
49 papers, 3.8k citations indexed

About

Daniel A. Rossignol is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Daniel A. Rossignol has authored 49 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cognitive Neuroscience, 32 papers in Psychiatry and Mental health and 30 papers in Genetics. Recurrent topics in Daniel A. Rossignol's work include Autism Spectrum Disorder Research (38 papers), Genetics and Neurodevelopmental Disorders (30 papers) and Child Nutrition and Feeding Issues (25 papers). Daniel A. Rossignol is often cited by papers focused on Autism Spectrum Disorder Research (38 papers), Genetics and Neurodevelopmental Disorders (30 papers) and Child Nutrition and Feeding Issues (25 papers). Daniel A. Rossignol collaborates with scholars based in United States, Qatar and Sri Lanka. Daniel A. Rossignol's co-authors include Richard E. Frye, Stephen J. Genuis, S. Jill James, Edward V. Quadros, J.M. Sequeira, Jeff Bradstreet, Shannon Rose, Dmitriy Niyazov, Michael J. Goldenthal and Stephen G. Kahler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Psychiatry and Neurobiology of Disease.

In The Last Decade

Daniel A. Rossignol

48 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis

2011 664 citations Daniel A. Rossignol, Richard E. Frye Molecular Psychiatry profile →
Environmental toxicants and autism spectrum disorders: a systematic review

2014 341 citations Daniel A. Rossignol, Richard E. Frye et al. profile →
Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis

2024 36 citations Richard E. Frye, Daniel A. Rossignol et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel A. Rossignol United States	27	2.2k	1.4k	1.4k	827	362	49	3.8k
Laila Al‐Ayadhi Saudi Arabia	41	2.2k 1.0×	1.3k 0.9×	988 0.7×	1.0k 1.2×	294 0.8×	168	4.5k
Alejandro Arias Vásquez Netherlands	41	1.6k 0.7×	668 0.5×	1.7k 1.2×	1.2k 1.5×	630 1.7×	163	4.9k
Carmela Bravaccio Italy	32	1.6k 0.7×	989 0.7×	1.1k 0.8×	919 1.1×	441 1.2×	112	3.6k
Lijie Wu China	28	1.2k 0.5×	507 0.4×	637 0.5×	430 0.5×	344 1.0×	100	2.1k
Patricia M. Rodier United States	30	1.6k 0.7×	1.2k 0.8×	419 0.3×	709 0.9×	190 0.5×	61	4.0k
Amirhossein Modabbernia Iran	30	744 0.3×	331 0.2×	1.2k 0.9×	398 0.5×	527 1.5×	68	3.5k
Michael Chez United States	19	1.4k 0.6×	788 0.6×	1.0k 0.8×	304 0.4×	202 0.6×	41	2.4k
Bernardo Dalla Bernardina Italy	35	798 0.4×	545 0.4×	1.9k 1.4×	369 0.4×	304 0.8×	110	3.2k
Marcel G. Smits Netherlands	38	2.4k 1.1×	312 0.2×	1.2k 0.9×	265 0.3×	197 0.5×	98	4.9k
Annamaria Cattaneo Italy	47	545 0.2×	396 0.3×	820 0.6×	1.6k 1.9×	736 2.0×	152	7.1k

Countries citing papers authored by Daniel A. Rossignol

Since Specialization

Citations

This map shows the geographic impact of Daniel A. Rossignol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Rossignol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Rossignol more than expected).

Fields of papers citing papers by Daniel A. Rossignol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Rossignol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Rossignol. The network helps show where Daniel A. Rossignol may publish in the future.

Co-authorship network of co-authors of Daniel A. Rossignol

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Rossignol. A scholar is included among the top collaborators of Daniel A. Rossignol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Rossignol. Daniel A. Rossignol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frye, Richard E., et al.. (2023). The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder. Journal of Personalized Medicine. 13(2). 252–252. 24 indexed citations

Gaitanis, John, et al.. (2023). Age-Related Changes in Epilepsy Characteristics and Response to Antiepileptic Treatment in Autism Spectrum Disorders. Journal of Personalized Medicine. 13(7). 1167–1167. 3 indexed citations

Frye, Richard E., et al.. (2019). Emerging biomarkers in autism spectrum disorder: a systematic review. Annals of Translational Medicine. 7(23). 792–792. 118 indexed citations

Frye, Richard E. & Daniel A. Rossignol. (2016). Treatments for mitochondrial dysfunction associated with autism spectrum disorders. 2(4). 241–249. 1 indexed citations

Frye, Richard E. & Daniel A. Rossignol. (2016). Mitochondrial and metabolic abnormalities in neurodevelopmental disorders. 2(4). 177–180. 2 indexed citations

Frye, Richard E. & Daniel A. Rossignol. (2016). Metabolic disorders and abnormalities associated with autism spectrum disorder. 2(4). 181–191. 2 indexed citations

Rossignol, Daniel A. & Richard E. Frye. (2016). Folate receptor alpha autoimmunity and cerebral folate deficiency in autism spectrum disorders. 2(4). 263–271. 2 indexed citations

Rossignol, Daniel A. & Richard E. Frye. (2014). Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Frontiers in Physiology. 5. 150–150. 285 indexed citations

Rossignol, Daniel A. & Richard E. Frye. (2014). The Use of Medications Approved for Alzheimerâ€™s Disease in Autism Spectrum Disorder: A Systematic Review. Frontiers in Pediatrics. 2. 87–87. 58 indexed citations

10.

Frye, Richard E., Jeffrey M. Sequeira, Edward V. Quadros, & Daniel A. Rossignol. (2014). Folate Receptor Alpha Autoantibodies Modulate Thyroid Function in Autism Spectrum Disorder. North American Journal of Medicine and Science. 7(2). 53–53. 5 indexed citations

11.

Frye, Richard E. & Daniel A. Rossignol. (2014). Treatments for Biomedical Abnormalities Associated with Autism Spectrum Disorder. Frontiers in Pediatrics. 2. 66–66. 61 indexed citations

12.

Rossignol, Daniel A. & Richard E. Frye. (2014). Melatonin in Autism Spectrum Disorders. Current Clinical Pharmacology. 9(4). 326–334. 59 indexed citations

13.

Rossignol, Daniel A., James Jeffrey Bradstreet, Cindy Schneider, et al.. (2012). Hyperbaric oxygen treatment in autism spectrum disorders. Medical Gas Research. 2(1). 16–16. 29 indexed citations

14.

Rossignol, Daniel A. & Richard E. Frye. (2011). Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Molecular Psychiatry. 17(3). 290–314. 664 indexed citations breakdown →

15.

Frye, Richard E. & Daniel A. Rossignol. (2011). Mitochondrial Dysfunction Can Connect the Diverse Medical Symptoms Associated With Autism Spectrum Disorders. Pediatric Research. 69(5 Part 2). 41R–47R. 171 indexed citations

16.

Rossignol, Daniel A. & Richard E. Frye. (2011). A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Molecular Psychiatry. 17(4). 389–401. 416 indexed citations

17.

Rossignol, Daniel A. & Richard E. Frye. (2011). Melatonin in autism spectrum disorders: a systematic review and meta‐analysis. Developmental Medicine & Child Neurology. 53(9). 783–792. 319 indexed citations

18.

Rossignol, Daniel A., et al.. (2009). Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatrics. 9(1). 21–21. 62 indexed citations

19.

Bradstreet, James Jeffrey, Scott A. Smith, Doreen Granpeesheh, J.M. El-Dahr, & Daniel A. Rossignol. (2006). Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders. Medical Hypotheses. 68(5). 979–987. 31 indexed citations

20.

Rossignol, Daniel A., et al.. (1999). Accelerated Transplant Coronary Artery Disease and Massive Silent Acute Myocardial Infarction in a Heart Transplant Patient. Angiology. 50(11). 947–953. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact